ClinicalTrials.gg
RecruitingNCT03830879Updated Nov 19, 2026

Shenzhen Birth Cohort Study

An observational study in Pregnancy Complications, Gestational Diabetes and Obstetric Labor Complications, sponsored by Sun Yat-sen University. Recruiting at 1 site in China. Open to participants aged 15 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-19.

Sponsored by Sun Yat-sen University · Observational

How we know

From the registry’s dates

  • Started Mar 2018; still recruiting 8 years 8 months later.
Updated Nov 19, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
10,000
Ages
15 Years to 49 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 18 studies in Pregnancy Complications with a site in China — 9 open to participants now, 10 under way, none of them phase 3. Pregnancy Complications · China.

Planned enrollment
4th of 11
10,000 · median 5,216
Started
2018
with 2 others
Observational
11 of 18
6 open now
Registered
5th of 18
by date
Lead sponsor
2 of 18
Sun Yat-sen University

Among the 18 studies in Pregnancy Complications with a site in China, this one is the 4th largest by planned enrollment of the 11 observational ones that give a count, is one of 3 that started in 2018, is one of 11 observational ones, and was the 5th registered.

Pregnancy Complications

411 studies on the registry are indexed under Pregnancy Complications; 111 are open to participants now.

Browse Pregnancy Complications studies →

Open to participants now

9 of the 18 studies in Pregnancy Complications with a site in China are open now. Recruiting first, the newest first:

3 more — sign in →

All 9 open studies →

A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →

Who these studies take

Of the 90 Pregnancy Complications studies recruiting now, 43 (48%) set no upper age limit and 44 (49%) stop at 75 or younger; 22 take children under 18; 35 take healthy volunteers.

This study: 15 Years to 49 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 18 studies in Pregnancy Complications with a site in China, or all of them as a file.
02

Study summary

The Shenzhen Birth Cohort Study was set up to investigate the effect of early life environmental exposures on short- and long-term health consequences in Shenzhen, China.

Read the detailed description

Shenzhen Birth Cohort (Xinmiao Project) is a scientific research/public health project under the support of Shenzhen city and Nanshan district, which was jointly initiated by Nanshan Maternity and Child Healthcare Hospital of Shenzhen and school of public health, Sun Yat-sen University. The project plans to recruit 10,000 participants in early pregnancy and follow up for seven years in the first stage. Biological samples, questionnaires and data for child growth and development, disease and health will be collected. The study is aimed to provide evidence for DOHaD Hypothesis and find the prevention and control measures for some childhood diseases. The core members of the research team are composed of experts from different disciplines in the field of public health, including 4 professors and 3 associate professors. With the support of an executive sponsor, the project is undertaken by the Birth Cohort Study Center. Currently, the center has 3 staff form hospital (one doctor and two masters ) and 5-7 master candidates from Sun Yat-sen University. It is an energetic and enthusiastic team.

03

Conditions studied

  • Pregnancy Complications
  • Gestational Diabetes
  • Obstetric Labor Complications
  • Neurodevelopmental Disorders
  • Childhood Obesity
04

Who can participate

Ages eligible
15 Years to 49 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Pregnant women attending their first routine antenatal examinations and their partners and offspring.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • 1. Pregnant women plan to delivery and participate in child care in our hospital; 2. Pregnant women plan to reside in Shenzhen for at least 7 years; 3. Pregnant women who show interest in the study and agree to provide ; 4. Gestational weeks are less than 20 weeks.Those who will agree that their neonatal will be included in the study and be followed up regularly in our child health clinic until an age of 7 years.

Exclusion criteria

Exclusion Criteria:

  • Pregnant women who have been pregnant for more than 20 weeks; refuse to participate; unable to guarantee delivery in our hospital or can't participate in child care in our hospital; mentally incapacitated and need guardians; or be unwilling to sign .
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
10,000 participants (estimated)
Patient registry
No
Biospecimen retention
Samples with dna

Groups and cohorts

  • No treatment

    This cohort study have any no treatment.

    Other: No intervention

Interventions

  • OtherNo intervention

    This cohort study have any no intervention.

06

What researchers measure

Primary outcomes

  1. Fetal outcomes.

    Including intrauterine growth retardation, abortion, stillbirth, live birth, preterm. birth, low birth weight, macrosomia and birth defects.

    Time frame: At delivery.

Secondary outcomes

  1. Maternal weight changes (kg).

    Assess using electronic weighing machine.

    Time frame: At pre-pregnancy period, 20 weeks of gestation, 28 weeks of gestation, the time before labor and 30 days after delivery.

  2. Number of participant with gestational complications.

    Including gestational hypertension and preeclampsia, and gestational diabetes mellitus.

    Time frame: At delivery.

  3. Number of participant with postnatal depression.

    Assess using Edinburgh Postnatal Depression Scale (EPDS).

    Time frame: At 30 days after delivery, 3 months, 6 months after delivery.

  4. Physical development.

    Including weight changes (kg) and height changes (cm).

    Time frame: at age of 1 month, 3 months, 6months, 1 year, 3 years and 6 years.

  5. Neurodevelopment.

    Including gross motor, fine motor, language, and social function, assess using Ages and Stages Questionnaires (ASQ-3 and ASQ-SE).

    Time frame: at age of 1 month, 3 months, 6months, 1 year, 3 years and 5 years.

07

Study locations

1 of 1 sites recruiting
  • RuiGao
    Shenzhen, Guangdong 510000, China
    Recruiting
    • Rui Gao · Contactruigao@szbcs.org · 86 13554809095
    • Weiqing Chen, Professor · Principal investigator
    • Yuantao Hao, Professor · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2018 (actual). Primary completion is estimated for Dec 2030, 153 months after the start.

Of 113 non-industry observational studies under Pregnancy Complications, half reached primary completion within 60 months of starting (the median), counting those still running; a quarter within 30 and three quarters within 201. This study's planned 153 months is above that.

Counting every sponsor, half of 121 studies reached it within 60 months; a quarter within 30 and three quarters within 201.

Primary completion moved once since we started tracking on Sep 25, 2026: Mar 2025 → Dec 2030, on Nov 19, 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jan 30, 2019
First posted
Feb 5, 2019
StartActual
Mar 6, 2018
Primary completionEst.
Dec 31, 2030was Mar 2025
CompletionEst.
Dec 31, 2032
Last update
Nov 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Mar 5, 2025→Dec 31, 2030
Nov 19, 2026
Show all 1 update
  1. Nov 19, 2026
    Primary completion Mar 5, 2025→Dec 31, 2030
    + 3 other changes: verification date, responsible party and criteria formatting

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03830879
Responsible party
Li Cai, PhD (Associate professor, Sun Yat-sen University) — Principal investigator
First posted
Feb 5, 2019
Start date
Mar 6, 2018
Primary completion
Dec 31, 2030 (estimated)
Completion
Dec 31, 2032 (estimated)
Last update
Nov 19, 2026

Study contacts

Li Cai
Contact
caili5@mail.sysu.edu.cn
0086 20 87334956
Lihua Huang
Contact
hlihua2@mail2.sysu.edu.cn
0086 13570401256

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion